Interestingly, tissue factor expression (Fig. 5D), a well-established clot-activating transmembrane receptor, which is upregulated in stroke, was unchanged by acute in-vitro TMAO incubation with 10−6 M, but significantly increased when TMAO was added at 10−4 M (SOM Fig. 3F). This evidence concerns the gene NRP1 and stroke disorder.